Side effects from taking too much vitamin B6—including nerve damage—may be more widespread than we think, Australia's ...

In This Article, You'll Discover Understanding how NerveFreedom's unique formulation addresses multiple aspects of ner ...

Under the new law, licensed Florida physicians may administer ACP-01 (VesCell) for ischemia-related pain in conditions such ...

Many Australians take supplements hoping to support their general wellbeing, but it’s easier than a lot of us realise to consume more than is safe.

In Japan alone, around 4,000 individuals have a CIDP diagnosis. Sanofi neurology development global head Erik Wallstroem ...

VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to ...

Waking up with neck pain could be a sign that your pillow or sleeping position doesn't support your neck. Learn about all potential causes, plus treatment and prevention.

Cancer survivors often experience persistent physical symptoms long after treatment ends. Expert advice highlights holistic ...

Shares of Artelo Biosciences, Inc. (ARTL) more than doubled on Monday after the company announced favorable results from its ...

Japanese MHLW grants orphan drug designation to Sanofi’s riliprubart for chronic inflammatory demyelinating polyneuropathy: Paris Tuesday, July 1, 2025, 09:00 Hrs [IST] The Mini ...

Paris: Sanofi has received orphan drug designation from the Ministry of Health, Labour and Welfare (MHLW) in Japan for ...

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy  Two phase 3 studies are currently underway testing riliprubart in people with CIDP as a ...